Drug interactions for the following drug(s)
Applies to: gabapentin 100 MG Oral Capsule <> gabapentin 100 MG Oral Capsule
The risk or severity of adverse effects can be increased when Gabapentin is combined with gabapentin enacarbil.
Applies to: vitamin D 50000 UNT Oral Capsule <> Digoxin 0.125 MG Oral Tablet
Ergocalciferol may increase the arrhythmogenic activities of Digoxin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: gabapentin 100 MG Oral Capsule <> gabapentin 100 MG Oral Capsule
Drug1 (rxcui = 310430, name = gabapentin 100 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 310430, name = gabapentin 100 MG Oral Capsule, tty = SCD). Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Gabapentin Enacarbil and Gabapentin. Drug1 is resolved to gabapentin, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Gabapentin and Gabapentin Enacarbil.
Applies to: vitamin D 50000 UNT Oral Capsule <> Digoxin 0.125 MG Oral Tablet
Drug1 (rxcui = 1367410, name = Ergocalciferol 50000 UNT Oral Capsule, tty = SCD). Drug2 (rxcui = 197604, name = Digoxin 0.125 MG Oral Tablet, tty = SCD). Drug1 is resolved to Ergocalciferol, Drug2 is resolved to Digoxin and interaction asserted in DrugBank between Ergocalciferol and Digoxin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.